AIxCrypto Holdings, Inc. (AIXC)
1.09
+0.05
(+4.81%)
USD |
NASDAQ |
Sep 18, 16:00
1.11
+0.02
(+1.83%)
After-Hours: 20:00
AIxCrypto Holdings Shareholders Equity (Quarterly) : 5.682M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.682M |
| March 31, 2026 | 21.87M |
| December 31, 2025 | 27.95M |
| September 30, 2025 | 38.55M |
| June 30, 2025 | -1.652M |
| March 31, 2025 | 0.0331M |
| December 31, 2024 | 2.679M |
| September 30, 2024 | -2.141M |
| June 30, 2024 | -4.278M |
| March 31, 2024 | -3.522M |
| December 31, 2023 | -2.104M |
| September 30, 2023 | -1.641M |
| June 30, 2023 | 2.034M |
| March 31, 2023 | 4.869M |
| December 31, 2022 | 7.236M |
| September 30, 2022 | 12.15M |
| June 30, 2022 | 14.47M |
| March 31, 2022 | 13.52M |
| December 31, 2021 | 16.56M |
| September 30, 2021 | 10.85M |
| June 30, 2021 | 12.26M |
| March 31, 2021 | 16.23M |
| December 31, 2020 |
| Date | Value |
|---|---|
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | 5.015M |
| December 31, 2019 | 1.10M |
| September 30, 2019 | 0.0629M |
| June 30, 2019 | 2.136M |
| March 31, 2019 | 4.829M |
| December 31, 2018 | 9.386M |
| September 30, 2018 | 10.44M |
| June 30, 2018 | 14.92M |
| March 31, 2018 | 18.33M |
| December 31, 2017 | 20.13M |
| September 30, 2017 | 1.202M |
| June 30, 2017 | 3.01M |
| March 31, 2017 | 2.724M |
| December 31, 2016 | 4.103M |
| September 30, 2016 | 4.941M |
| June 30, 2016 | 8.126M |
| March 31, 2016 | 11.94M |
| December 31, 2015 | 14.68M |
| September 30, 2015 | 15.44M |
| June 30, 2015 | 17.35M |
| March 31, 2015 | 1.121M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cibus, Inc. | 14.80M |
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| NovelStem International Corp. | -2.032M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.403M |
| Total Liabilities (Quarterly) | 1.721M |
| Debt to Equity Ratio | 0.007 |
| Current Ratio | 3.682 |
| Net Debt Paydown Yield | 0.67% |